Research
Mixed
Comorbidities including obesity (48.6%), hypertension (54.7%), and hypercholesterolemia (31.6%) are highly prevalent in Korean adults with diabetes, yet control rates for these conditions are suboptimal.
Diabetes rarely comes alone. Nearly half of diabetic adults are obese, and more than half have high blood pressure. Managing your weight and diet is crucial not just for blood sugar, but for controlling blood pressure and cholesterol, which together determine your heart health.
GoodSupportsHIGH confidence
Of the subjects with diabetes, 48.6% and 54.7% were obese and hypertensive, respectively, and 31.6% had hypercholesterolemia... 69.1% reached the BP target goal... The prevalence and control rate of hypercholesterolemia were 31.6% and 49.8%, respectively.
Why this rating
Large, nationally representative data with objective measurements of BP, lipids, and BMI.
Source
Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
Jong Chul Won et al. · Diabetes & Metabolism Journal · 2018
DOI 10.4093/dmj.2018.0017
cross_sectional · n=10595Cited 302×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- In Korean adults aged 30 and older, diabetes prevalence is 13.7% (4.8 million) and impaired fasting glucose (prediabetes) prevalence is 24.8% (8.3 million), with prevalence increasing significantly with age and lower family income.Good
- Despite high rates of medical treatment (89.1% of diagnosed diabetics), glycemic control remains poor, with only 23.3% achieving the target HbA1c <6.5% and 43.5% achieving <7.0%.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →